Distribution of the rates of testing and prescribing by increasing time period across organizations and clinical practice sites
| Percent of patients with ≥1 test or prescription in time period . | Organizations (n = 24), median (10th–90th percentile), % . | Clinical practice sites (n = 1,164), median (10th–90th percentile), % . |
|---|---|---|
| eGFR and uACR | ||
| 1 year | 51.6 (44.1–61.9) | 53.8 (11.9–73.4) |
| 2 years | 69.3 (54.7–78.7) | 72.8 (22.7–89.7) |
| 3 years | 73.4 (57.4–82.2) | 78.6 (26.7–92.3) |
| eGFR | ||
| 1 year | 89.5 (86.2–91.6) | 90.0 (70.8–95.9) |
| 2 years | 96.1 (94.8–97.6) | 97.1 (86.5–99.3) |
| 3 years | 97.1 (95.7–98.5) | 98.0 (88.4–99.7) |
| uACR | ||
| 1 year | 52.9 (44.7–63.3) | 55.3 (13.3–75.4) |
| 2 years | 69.7 (54.8–79.1) | 73.3 (23.3–90.2) |
| 3 years | 73.7 (57.5–82.5) | 78.9 (27.7–92.5) |
| eGFR and any urine protein test† | ||
| 1 year | 66.4 (58.9–72.4) | 67.0 (36.9–81.1) |
| 2 years | 82.1 (76.3–87.7) | 85.2 (54.1–93.9) |
| 3 years | 86.0 (80.0–91.3) | 89.2 (57.5–95.8) |
| Urine albumin concentration | ||
| 1 year | 57.1 (44.8–63.8) | 59.2 (22.3–75.8) |
| 2 years | 71.5 (58.3–80.8) | 76.8 (34.0–90.6) |
| 3 years | 76.1 (61.5–84.1) | 81.6 (37.1–92.8) |
| Urine dipstick | ||
| 1 year | 31.2 (22.3–48.6) | 24.7 (14.5–50.4) |
| 2 years | 43.4 (32.2–62.2) | 36.3 (22.9–64.7) |
| 3 years | 51.2 (38.7–69.2) | 43.8 (27.7–70.7) |
| uPCR | ||
| 1 year | 1.3 (0.1–3.3) | 1.0 (0.0–4.3) |
| 2 years | 1.8 (0.1–4.2) | 1.5 (0.0–5.7) |
| 3 years | 2.1 (0.2–5.1) | 1.8 (0.0–6.4) |
| eGFR and any urine protein or ACE inhibitor or ARB prescribing | ||
| 1 year | 80.1 (76.8–84.9) | 80.8 (56.6–90.1) |
| 2 years | 91.0 (88.3–93.1) | 92.2 (70.8–96.9) |
| 3 years | 92.6 (90.4–95.0) | 94.3 (74.4–98.0) |
| ACE inhibitor or ARB prescribing | ||
| 1 year | 63.0 (58.2–67.0) | 62.9 (44.7–73.5) |
| 2 years | 68.4 (65.8–72.0) | 67.9 (52.0–77.6) |
| 3 years | 70.9 (67.7–73.7) | 70.1 (54.3–79.2) |
| HbA1c | ||
| 1 year | 91.1 (86.7–92.3) | 91.7 (72.3–96.2) |
| 2 years | 95.4 (92.8–97.0) | 96.7 (82.1–98.8) |
| 3 years | 96.3 (93.6–97.6) | 97.4 (83.9–99.2) |
| Percent of patients with ≥1 test or prescription in time period . | Organizations (n = 24), median (10th–90th percentile), % . | Clinical practice sites (n = 1,164), median (10th–90th percentile), % . |
|---|---|---|
| eGFR and uACR | ||
| 1 year | 51.6 (44.1–61.9) | 53.8 (11.9–73.4) |
| 2 years | 69.3 (54.7–78.7) | 72.8 (22.7–89.7) |
| 3 years | 73.4 (57.4–82.2) | 78.6 (26.7–92.3) |
| eGFR | ||
| 1 year | 89.5 (86.2–91.6) | 90.0 (70.8–95.9) |
| 2 years | 96.1 (94.8–97.6) | 97.1 (86.5–99.3) |
| 3 years | 97.1 (95.7–98.5) | 98.0 (88.4–99.7) |
| uACR | ||
| 1 year | 52.9 (44.7–63.3) | 55.3 (13.3–75.4) |
| 2 years | 69.7 (54.8–79.1) | 73.3 (23.3–90.2) |
| 3 years | 73.7 (57.5–82.5) | 78.9 (27.7–92.5) |
| eGFR and any urine protein test† | ||
| 1 year | 66.4 (58.9–72.4) | 67.0 (36.9–81.1) |
| 2 years | 82.1 (76.3–87.7) | 85.2 (54.1–93.9) |
| 3 years | 86.0 (80.0–91.3) | 89.2 (57.5–95.8) |
| Urine albumin concentration | ||
| 1 year | 57.1 (44.8–63.8) | 59.2 (22.3–75.8) |
| 2 years | 71.5 (58.3–80.8) | 76.8 (34.0–90.6) |
| 3 years | 76.1 (61.5–84.1) | 81.6 (37.1–92.8) |
| Urine dipstick | ||
| 1 year | 31.2 (22.3–48.6) | 24.7 (14.5–50.4) |
| 2 years | 43.4 (32.2–62.2) | 36.3 (22.9–64.7) |
| 3 years | 51.2 (38.7–69.2) | 43.8 (27.7–70.7) |
| uPCR | ||
| 1 year | 1.3 (0.1–3.3) | 1.0 (0.0–4.3) |
| 2 years | 1.8 (0.1–4.2) | 1.5 (0.0–5.7) |
| 3 years | 2.1 (0.2–5.1) | 1.8 (0.0–6.4) |
| eGFR and any urine protein or ACE inhibitor or ARB prescribing | ||
| 1 year | 80.1 (76.8–84.9) | 80.8 (56.6–90.1) |
| 2 years | 91.0 (88.3–93.1) | 92.2 (70.8–96.9) |
| 3 years | 92.6 (90.4–95.0) | 94.3 (74.4–98.0) |
| ACE inhibitor or ARB prescribing | ||
| 1 year | 63.0 (58.2–67.0) | 62.9 (44.7–73.5) |
| 2 years | 68.4 (65.8–72.0) | 67.9 (52.0–77.6) |
| 3 years | 70.9 (67.7–73.7) | 70.1 (54.3–79.2) |
| HbA1c | ||
| 1 year | 91.1 (86.7–92.3) | 91.7 (72.3–96.2) |
| 2 years | 95.4 (92.8–97.0) | 96.7 (82.1–98.8) |
| 3 years | 96.3 (93.6–97.6) | 97.4 (83.9–99.2) |
Urine protein tests include uACR, urine albumin concentration, urine dipstick, and uPCR.